FDA’s PMTA denials get a warm political welcome – but not the delay over Juul

The US Food and Drug Administration (FDA)’s denial of premarket tobacco product applications (PMTAs) has been mostly welcomed by politicians and public health organisations some of whom have urged the agency to deny Juul Labs’ application too.

US senator Dick Durbin of Illinois said he was glad to hear that the federal agency had rejected most of the applications but said it was “unacceptable” that the evaluation of Juul products had been postponed.

...

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Restricted content. Do you want to read more?

Request report

Interested in buying?
Request more information

MORE INFO

Visit store

Check out our reports
available for purchase

View reports

Request a free sample of this report:

“ FDA’s PMTA denials get a warm political welcome – but not the delay over Juul ”

    This file is not available, please fill the form to request your sample page:






    Buy report request information:

    “ FDA’s PMTA denials get a warm political welcome – but not the delay over Juul ”






      The US Food and Drug Administration (FDA)’s denial of premarket tobacco product applications (PMTAs) has been mostly welcomed by politicians and public health organisations some of whom have urged the agency to deny Juul Labs’ application too.

      US senator Dick Durbin of Illinois said he was glad to hear that the federal agency had rejected most of the applications but said it was “unacceptable” that the evaluation of Juul products had been postponed.

      ...

      Benefits of subscription plans:

      • Stay informed of any legal and market change in the sector that impacts your organization
      • Maximise resources by getting market and legal data analysis daily in one place
      • Make smart decisions by understanding how the regulatory and market landscape evolves
      • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

      Need help?

      Contact a sales representative right now and don’t wait

      Erik Galavis
      +34 654 320 547
      Email Erik